Recall Z-2452-2021— Cellex

Class II · Ongoing

Class II FDA medical device recall by Cellex, initiated 2021-03-01. FDA's recall record names no specific 510(k) clearance for this event. Product: Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue". Reason: The kit does not have an emergency use authorization (EUA)..

Recalling firm
Cellex
Classification
Class II
Status
Ongoing
Initiated
2021-03-01
Firm location
Morrisville, NC, United States

Product description

Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"

Reason for recall

The kit does not have an emergency use authorization (EUA).

Data sourced from openFDA. This site is unofficial and independent of the FDA.